Anterior is an AI-driven clinical workflow platform that automates and orchestrates administrative processes for health plans and healthcare payers[2]. Founded in 2023[3], the company operates in the New York artificial intelligence sector. In July 2026, Anterior announced a strategic partnership with Stellarus, a healthcare technology company spun out of Blue Shield of California, to enable health plans to deliver real-time AI-driven prior authorization decisions with clinician oversight[1].
Funding
- Venture, $40MFeb 12, 2026
with New Enterprise Associates, Sequoia Capital, FPV Ventures, Kinnevik
Key people
Recent developments
- Anterior partners with Stellarus on AI-driven prior authorization. Anterior announced a strategic partnership with Stellarus, a healthcare technology company spun out of Blue Shield of California, to let health plans deliver real-time AI-driven prior authorization decisions with clinician oversight.[1]Jul 23, 2026
Funding history
- Anterior raised $40M in venture funding led by New Enterprise Associates with Sequoia Capital, FPV Ventures and Kinnevik participating, bringing total reported equity funding to $64M. Founded in 2022 by Abdel Mahmoud and Zahid Mahmood.[4]Feb 12, 2026
Traction
- Anterior reports an 85% reduction in baseline administrative costs, a 56% decrease in staff burden time, 99.24% clinical accuracy verified by KLAS, a clinician satisfaction score of 92, and a payer case study processing 6 million prior authorizations annually.[7]
Product
- Anterior builds clinical AI for health plan workflows, describing its systems as transparent, modular and clinically accurate. The platform is split into Actions, modular AI tasks that apply across health plan processes, and Solutions, pre-configured implementations aimed at measurable return. Its flagship application is prior authorization review.[10]
Partnerships
- Anterior announced a strategic partnership with Stellarus, a healthcare technology company spun out of Blue Shield of California, to let health plans deliver real-time AI-driven prior authorization decisions with clinician oversight.[2]Jul 23, 2026
Backers
- FFPV Ventures
- FKinnevik
NEA
New Enterprise Associates, a venture capital firm investing in technology and healthcare from seed through IPO, with offices including Menlo Park.
- FNew Enterprise Associates
Sequoia Capital
Venture capital firm backing founders across AI, healthcare, retail and other sectors from early stage through growth.
Something wrong or missing? Send a correction. Fixed within 24 hours.